Tirzepatide, also known as LY3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily developed for research into type 2 diabetes treatment and weight management. With a molecular formula of C225H348N48O68 and a purity of 99.9%, this white powder is supplied in vials for laboratory use only.
Studies indicate that Tirzepatide demonstrates superior efficacy in glucose control and weight reduction compared to other agonists like Dulaglutide. Its unique dual agonist behavior targets both GIP and GLP-1 receptors, leading to significant hyperglycemia reduction. Clinical trials, such as SURMOUNT-1, have shown weight loss averages of 15-20.9% over 72 weeks, depending on dosage.
This product is intended for research purposes only and is not for human consumption. Proper storage guidelines include keeping the peptide in a cold, dry, dark place, avoiding repeated freeze-thaw cycles, and minimizing exposure to air and light. For bulk orders or custom requirements, please inquire about our competitive Tirzepatide UK price and flexible packaging options.